Artelo Biosciences (ARTL) Exchange Rate Effect (2017 - 2025)
Artelo Biosciences (ARTL) posted quarterly Exchange Rate Effect of -$4000.0 for Q4 2025, up 55.56% year-over-year from -$2571.4 in Q4 2024, and up 90.48% quarter-over-quarter from -$42000.0 in Q3 2025.
Artelo Biosciences (ARTL) Exchange Rate Effect (2017 - 2025) Analysis & Trends
Artelo Biosciences (ARTL) has reported Exchange Rate Effect for 9 consecutive years, with -$4000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Exchange Rate Effect rose 55.56% year-over-year to -$4000.0; the TTM figure through Dec 2025 stood at -$23000.0 (down 187.5% YoY), while the FY2025 annual figure was -$23000.0, down 187.5% from the prior year.
- Exchange Rate Effect improved to -$4000.0 in Q4 2025 per ARTL's latest filing, from -$42000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $115000.0 in Q4 2022 and bottomed at -$210000.0 in Q3 2022.
- Historically, Exchange Rate Effect has averaged -$12588.9 across 5 years, with a median of -$1000.0 in 2023.
- On a YoY basis, Exchange Rate Effect climbed as much as 1900.0% in 2025 and fell as far as 1150.0% in 2025.
- Artelo Biosciences' Exchange Rate Effect stood at -$40000.0 in 2021, then jumped by 387.5% to $115000.0 in 2022, then sank by 100.87% to -$1000.0 in 2023, then sank by 800.0% to -$9000.0 in 2024, then surged by 55.56% to -$4000.0 in 2025.
- Business Quant data shows ARTL's Exchange Rate Effect at -$4000.0 in Q4 2025, -$42000.0 in Q3 2025, and $18000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.41 Bn | 131.56 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 86.14 Bn | 78.15 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 65.52 Bn | 60.34 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.21 Bn | 53.07 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | -2.45 Mn |
| 7 | BioNTech SE | 27.95 Bn | 9.56 Bn | 668.28 Mn | 1.63 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -287,000.00 |
| 9 | Royalty Pharma | 27.30 Bn | 26.46 Bn | - | - |
| 10 | Artelo Biosciences | 112,390.15 | -487,609.85 | - | -4,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4,000.00 |
| Dec 31, 2025 | -4,000.00 |
| Sep 30, 2025 | -42,000.00 |
| Sep 30, 2025 | -42,000.00 |
| Jun 30, 2025 | 18,000.00 |
| Jun 30, 2025 | 18,000.00 |
| Mar 31, 2025 | 5,000.00 |
| Mar 31, 2025 | 5,000.00 |
| Dec 31, 2024 | -9,000.00 |
| Dec 31, 2024 | -9,000.00 |
| Sep 30, 2024 | 4,000.00 |
| Sep 30, 2024 | 4,000.00 |
| Jun 30, 2024 | -1,000.00 |
| Jun 30, 2024 | -1,000.00 |
| Mar 31, 2024 | -2,000.00 |
| Mar 31, 2024 | -2,000.00 |
| Dec 31, 2023 | -1,000.00 |
| Dec 31, 2023 | -1,000.00 |
| Sep 30, 2023 | 19,000.00 |
| Sep 30, 2023 | 19,000.00 |